Aprea Therapeutics logo

Aprea Therapeutics

APRE | NASDAQ
Chart Builder DCF Calculator
$0.45
-$0.05 (-10.18%)
At close: Nov 10, 2026, 4:00 PM ET
-10.18%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 10, 2026
36.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #630/1027 (Top 61%)

Key Statistics

Market Data

Market Cap $5.61M
1D Range
0.44 0.51
52W Range
0.44 1.32

Valuation (TTM)

PE -0.64
PB 0.16
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $2.10
Loading financial charts...

Profile

Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on mo...

Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Oct 3, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$2.10
Upside
+366.67%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.